Golden Dragon (CPMD) Stock Price, News & Analysis

Company Overview

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

Key Stats

• Today's Range: $0.0024 to $0.0024
• 50-Day Range: N/A
• 52-Week Range: $0.0003 to $0.01
• Volume: N/A
• Average Volume: 163,378 shs
• Market Capitalization: $1.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Golden Dragon Stock Analysis - MarketRank™

Golden Dragon scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Golden Dragon.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Golden Dragon is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Golden Dragon is -0.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Golden Dragon has been sold short.

Short Interest Ratio / Days to Cover

Golden Dragon has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Golden Dragon has recently increased by 100.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Golden Dragon does not currently pay a dividend.

Dividend Growth

Golden Dragon does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Golden Dragon has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Golden Dragon this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Golden Dragon insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.27% of the stock of Golden Dragon is held by insiders.

Percentage Held by Institutions

Golden Dragon has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 3/31/2026
• Today: 6/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CPMD
• CIK: 1081938
• Web: www.cannapharmarx.com
• Phone: (949) 652-6838
• Fax: 720-875-1905
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.13 million
• Net Margins: -654.02%
• Pretax Margin: -653.90%
• Return on Equity: N/A
• Return on Assets: -118.00%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.36 million
• Price / Sales: 1.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.05) per share
• Price / Book: -0.05

Miscellaneous

• Outstanding Shares: 706,820,000
• Free Float: 697,838,000
• Market Cap: $1.70 million
• Optionable: Not Optionable
• Beta: 2.03